Especially about the new generation of semaglutide-based injectable weight loss drugs such as Ozempic and Wegovy. These two weight loss drugs have been prescribed by doctors in the West to ...
U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...